Xing, S., Cheng, X., Hou, S., Qin, L., Wang, J., Ding, Y., . . . Zhu, D. (2026). Identification of monomethylsulochrin as a novel agent to ameliorate DSS-induced ulcerative colitis through dual modulation of the IL-17/TNF pathway and gut microbiota. International immunopharmacology.
Chicago-Zitierstil (17. Ausg.)Xing, Shangping, et al. Identification of Monomethylsulochrin as a Novel Agent to Ameliorate DSS-induced Ulcerative Colitis Through Dual Modulation of the IL-17/TNF Pathway and Gut Microbiota. International immunopharmacology, 2026.
MLA-Zitierstil (9. Ausg.)Xing, Shangping, et al. Identification of Monomethylsulochrin as a Novel Agent to Ameliorate DSS-induced Ulcerative Colitis Through Dual Modulation of the IL-17/TNF Pathway and Gut Microbiota. International immunopharmacology, 2026.